Prognostic factors of ulcer healing and amputation-free survival in patients with critical limb ischemia.
Tadashi FuruyamaToshihiro OnoharaSho YamashitaRyosuke YoshigaKeiji YoshiyaKentaro InoueKoichi MorisakiRyoichi KyuragiTakuya MatsumotoYoshihiko MaeharaPublished in: Vascular (2018)
Ulcer healing within 90 days after arterial revascularization is impaired by no cilostazol use, a white blood cell count >10,000, a major defect after debridement, and endovascular therapy. Furthermore, cilostazol improves amputation-free survival rate in patients with critical limb ischemia.